Table 1 Summary data for 265 patients.
Age, years, mean ± SD | 68.9±12.6 |
Gender, male (%)/female (%) | 152 (57.4)/113 (42.6) |
Underlying disorders, n (%) | |
Cervical spondylosis | 60 (22.6) |
Ossification of longitudinal ligament | 38 (14.3) |
Spinal cord injury | 22 (8.3) |
Lumbar spinal canal stenosis | 145 (54.7) |
Past spine operation, n (%) | 106 (40.0) |
Comorbidity of diabetes, n (%) | 79 (29.8) |
Neurological symptoms, n (%) | |
Spinal cord-related pain | 87 (32.8) |
Radicular pain | 96 (36.2) |
Cauda equina syndrome | 82 (30.9) |
Drug, n (number of patients taking concomitant tramadol) | |
Pregabalin | 109 (40) |
Mirogabalin | 63 (20) |
Duloxetine | 54 (8) |
Neurotropin | 39 (0) |
Median daily prescription dose (approved dose), mg or units | |
Pregabalin | 150 (300) |
Mirogabalin | 20 (30) |
Duloxetine | 40 (40 or 60) |
Neurotropin | 16 (16) |
Tramadol | 100 (150) |
